Treatment with oral paricalcitol in daily clinical practice for patients with chronic kidney disease stage 3–4: a preliminary study

BACKGROUND: Active vitamin D is an effective treatment for secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD) patients often complicated by hypercalcaemia and hyperphosphataemia. Treatment with paricalcitol, a selective vitamin D receptor activator, has shown benefits by adequately...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadjiyannakos, Dimitrios, Filiopoulos, Vassilis, Trompouki, Sofia, Sonikian, Makroui, Karatzas, Ioannis, Panagiotopoulos, Konstantinos, Vlassopoulos, Dimosthenis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432442/
https://www.ncbi.nlm.nih.gov/pubmed/26019845
http://dx.doi.org/10.1093/ckj/sfs188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4432442/
https://www.ncbi.nlm.nih.gov/pubmed/26019845
http://dx.doi.org/10.1093/ckj/sfs188

Ejemplares similares